Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...

While many use marijuana for managing chronic pain or as a way to unwind at the end of the day, according to UW Medicine, ...

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

As COVID completes its sixth year, official statistics obscure the scale of harm, while Long COVID and excess deaths reveal ...

Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence ...

A recent study finds that six specific depressive symptoms in midlife may increase the risk of dementia later in life by ...

At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...

Presence of inherited blindness gene does not guarantee vision loss. Only 28% of carriers develop disease, indicating other ...